COPD Polygenic Transcriptome Risk Scores for COPD Show Improved Cross-Ancestry Portability Researchers found that polygenic transcriptome risk scores worked better across ethnicities than polygenic risk scores to predict chronic obstructive pulmonary disease risk. COPD Genetic Risk Factors Vary by Patient Sex, Suggests Research Presented at AMIA With the help of an internally self-developed analytics tool, University of Pennsylvania researchers run GWAS to uncover sex-specific genetic associations for COPD risk. COPD Genome-Wide Association Study Reveals Numerous Risk Variants The two genome-wide association studies of chronic obstructive pulmonary disease uncovered numerous novel risk variants, including ones in genes involved in ciliogenesis and lung development. Genomics Medicine Ireland, Academic Collaborators to Study Asthma Genetics The partners aim to identify genetic factors common to individuals with asthma and asthma-chronic obstructive pulmonary disease overlap syndrome. Owlstone Medical, AstraZeneca Ink Deal for Breath Biomarker Platform Owlstone will give AstraZeneca access to its Breath Biopsy Services to identify breath-based biomarkers for stratifying and treating asthma and COPD patients. Nov 14, 2017 Hummingbird Diagnostics, Saarland University Form Biomarker Validation Partnership May 31, 2017 Q&A: Dana-Farber's Quackenbush Ties SNP Analysis to Networks Premium Jan 24, 2017 Rare Variants Influence COPD Risk, Targeted Sequencing Study Finds Jan 11, 2017 COPD Foundation, Bio-Techne Test Predictive Emphysema Biomarker May 6, 2016 BioScale Changes Name to ProterixBio, Shifts Focus From Instruments to Diagnostics Premium Sep 28, 2015 GWAS Yields New Loci Linked to Lung Function, Smoking Behavior Dec 15, 2014 Glyconics Inks Exclusive Licensing Deal with Swansea U for COPD Biomarker Detection Jun 4, 2014 Glyconics Launches with FTIR Technology to Detect COPD, Other Respiratory Diseases Dec 5, 2013 University of British Columbia Team Lands C$7.2M to Develop COPD Dx Dec 5, 2012 HTG to Commercialize PROOF's COPD Risk Stratification Test; Aims for Launch Next Year Premium Nov 27, 2012 HTG Molecular Dx Licenses PROOF Centre COPD Testing Tech Apr 25, 2012 Canada's PROOF Center to Develop Risk Stratification Test to Personalize COPD Treatment Premium Apr 17, 2012 PROOF Centre Uses Genome BC Funds for COPD Dx Jan 19, 2012 UPenn Gets $2.5M for Lung Repair, Regeneration Studies Jul 30, 2010 Thermo Fisher to Collaborate with Japanese Researchers on Tokyo-Based Biomarker Research Center Premium Mar 8, 2010 NIH Plans $24M for Lung Cancer-COPD Genotype, Phenotype Studies Feb 4, 2010 University of Pittsburgh Earmarks $350K from NIH Grant for WaferGen Real-Time PCR Studies Premium Apr 22, 2009 Celera 'Expediting' Lung Cancer Dx Development Based on Promising Study Results Premium Apr 2, 2009 Proteros Fragments Inks First Deal to Uncover Protein Structure of Novel Protein Found by Axikin Pharma Premium Breaking News Long COVID Clues Found in Acute SARS-CoV-2 Infection Blood Samples People in the News at Roche, Mammoth Biosciences, NeoGenomics, Molecular Assemblies, More New Products Posted to GenomeWeb: Thermo Fisher, Element Biosciences, Dante Genomics, More Tesis Biosciences to Develop miRNA Biomarkers for mTBI Diagnosis In Brief This Week: Danaher, Lucira Health, Novacyt, Molecular Devices The Scan Cell Atlas of Human Lung Development Gives View of Developing Airway Researchers have generated a cell atlas of human lung development, which they report in Cell. Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis. Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity. Study Links Genetic Risk for ADHD With Alzheimer's Disease A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.